RE:RE:RE:Deals are abound!!!!fox7mf wrote: It's interesting how you don't see a competitive buyout offer for a biotech with possibly two ph3's on the horizon, when preclinicals in similar spaces are being gobbled up in multi billion dollar deals. We'll see I guess.
It's the other possibilty... biding war.